Publications by authors named "Rachel C Morgan"

Claim this Profile
H
Hypoglycemia in a Patient With a Polyhormonal Pancreatic Neuroendocrine Tumor With Evidence of Endocrine Progenitors.
Zachary B Simons, Rachel C Morgan, Laurel Rose, Jennifer B Nelson, Sarah A Tersey

J Endocr Soc· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).
Isabel Syndikus, Rachel C Morgan, Matthew R Sydes, John D Graham, David P Dearnaley

Int J Radiat Oncol Biol Phys· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.
Sarah L Gulliford, Kerwyn Foo, Rachel C Morgan, Edwin G Aird, A Margaret Bidmead

Int J Radiat Oncol Biol Phys· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.
Matthew R Sydes, Mahesh K B Parmar, Nicholas D James, Noel W Clarke, David P Dearnaley, Rachel C Morgan

Trials· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial.
Nicholas D James, Matthew R Sydes, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Rachel C Morgan

BJU Int· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer.
Ruth E Langley, Ian F Godsland, Howard Kynaston, Noel W Clarke, Stuart D Rosen, Rachel C Morgan

BJU Int· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy.
Chris Parker, Matthew R Sydes, Charles Catton, Howard Kynaston, John Logue, Rachel C Morgan

BJU Int· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial.
David P Dearnaley, Matthew R Sydes, John D Graham, Edwin G Aird, David Bottomley, Rachel C Morgan

Lancet Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis